Last Posted: Sep 05, 2019
- An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Piccinin Carolyn et al. Expert review of anticancer therapy 2019 Aug - Medication Use to Reduce Risk of Breast Cancer- US Preventive Services Task Force Recommendation Statement
USPSTF Recommendation, JAMA, September 3, 2019 - Multi gene panel testing for hereditary breast cancer - is it ready to be used?
Catana Andreea et al. Medicine and pharmacy reports 2019 Jul 92(3) 220-225 - Universal Genetic Testing for All Breast Cancer Patients.
Copur Mehmet Sitki et al. Oncology (Williston Park, N.Y.) 2019 Aug 33(8) - Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine?
M Daly et al, JAMA Oncology, September 3, 2019 - CHIPing away at breast cancer
AS Sperling, JNCI, August 2019 - Medications to Reduce Breast Cancer Risk-Promise and Limitations
LE Pace et al, JAMA, September 3, 2019 - Cancer Diagnosis Using Deep Learning: A Bibliographic Review.
Munir Khushboo et al. Cancers 2019 Aug 11(9) - Detection of early breast cancer beyond mammographic screening: a promising biomarker panel.
Hamann Moritz et al. Biomarkers in medicine 2019 Aug - The NCCN Criterion "Young Age at Onset" Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population.
Ebrahimi Elmira et al. Cancer prevention research (Philadelphia, Pa.) 2019 Aug
No hay comentarios:
Publicar un comentario